Copyright
©The Author(s) 2025.
World J Gastrointest Oncol. Apr 15, 2025; 17(4): 104922
Published online Apr 15, 2025. doi: 10.4251/wjgo.v17.i4.104922
Published online Apr 15, 2025. doi: 10.4251/wjgo.v17.i4.104922
Figure 1 N-acetyl-L-cysteine and Z-VAD-FMK inhibit tetramethylpyrazine-induced cell apoptosis.
A: Cell morphology of SW480 and HCT116 cells treated with tetramethylpyrazine (TMP) with or without Z-VAD-FMK and N-acetyl-L-cysteine (NAC) observed by inverted light microscopy; B: Percentage of apoptotic cells in SW480 and HCT116 cells treated with TMP with or without Z-VAD-FMK and NAC determined by flow cytometry; C: Cell survival rate of SW480 and HCT116 cells treated with TMP with or without Z-VAD-FMK and NAC. aP < 0.05. TMP: Tetramethylpyrazine; NAC: N-acetyl-L-cysteine.
- Citation: Hou YX, Ren W, He QQ, Huang LY, Gao TH, Li H. Tetramethylpyrazine induces reactive oxygen species-based mitochondria-mediated apoptosis in colon cancer cells. World J Gastrointest Oncol 2025; 17(4): 104922
- URL: https://www.wjgnet.com/1948-5204/full/v17/i4/104922.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v17.i4.104922